Suppr超能文献

锁骨下动脉慢性完全闭塞的血管内治疗的初始和长期结果。

Initial and long-term results of endovascular therapy for chronic total occlusion of the subclavian artery.

机构信息

Department of Vascular Surgery, Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia.

出版信息

Cardiovasc Intervent Radiol. 2012 Apr;35(2):255-62. doi: 10.1007/s00270-011-0144-8. Epub 2011 Mar 24.

Abstract

PURPOSE

To study the initial and long-term results of angioplasty and primary stenting for the treatment of chronic total occlusion (CTO) of the subclavian artery (SA).

MATERIALS AND METHODS

From January 1999 to February 2010, 56 patients (25 men with a mean age of 58 ± 8 years) underwent endovascular treatment for CTO of the SA. Duplex scans and arteriograms confirmed occlusion in all cases. Indications for recanalization were subclavian steal syndrome in 33 patients (58.1%), arm claudication in 13 patients (23.2%), and coronary ischemia in 7 patients (12.5%) who had a history of previous coronary artery bypass grafting that included left internal thoracic artery graft. Three patients (5.4%) were treated before the scheduled coronary artery bypass surgery, which included left internal thoracic artery graft. After successful recanalization, all arteries were stented, and all of the patients were followed-up at 1, 3, 6, and 12 months after surgery and annually thereafter.

RESULTS

Successful recanalization of the SA was achieved in 46 patients (82.1%), and the complication rate was 7.1%. During follow-up (mean 40 ± 26 months; range 2 to 125), the primary patency rates after 1 and 3 years were 97.9% and 82.7%, respectively. At the end of follow-up, 76% of the arteries showed no evidence of restenosis. Univariate analysis failed to identify any variable predictive of long-term patency of successfully recanalized SA.

CONCLUSION

Percutaneous transluminal angioplasty with stenting of the complete total occlusion of the SA is a safe and effective procedure associated with low risks and good long-term results.

摘要

目的

研究经皮腔内血管成形术和直接支架置入术治疗锁骨下动脉(SA)慢性完全闭塞(CTO)的即刻和长期疗效。

材料和方法

1999 年 1 月至 2010 年 2 月,56 例患者(25 例男性,平均年龄 58±8 岁)接受了 SA CTO 的血管内治疗。所有病例均经双功能超声和血管造影证实闭塞。血管再通的适应证为 33 例(58.1%)锁骨下窃血综合征、13 例(23.2%)手臂跛行和 7 例(12.5%)既往有包括左内乳动脉移植的冠状动脉旁路移植术病史的冠状动脉缺血。3 例(5.4%)患者在计划进行冠状动脉旁路移植术前接受治疗,其中包括左内乳动脉移植。SA 成功再通后,所有血管均进行支架置入,所有患者均在术后 1、3、6 和 12 个月以及此后每年进行随访。

结果

46 例(82.1%)患者 SA 成功再通,并发症发生率为 7.1%。在随访期间(平均 40±26 个月;范围 2 至 125 个月),1 年和 3 年的初始通畅率分别为 97.9%和 82.7%。随访结束时,76%的血管无再狭窄证据。单因素分析未能确定任何可预测成功再通的 SA 长期通畅率的变量。

结论

经皮腔内血管成形术联合支架置入治疗完全性 SA CTO 是一种安全有效的方法,风险低,长期效果好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验